ArticleFrontiers in microbiology2026
Large-scale plasmidome and carbapenem mobilome analysis reveals a mechanistic duality: high-power specialists and structural generalists mobile genetic elements.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antibiotic-Driven Gut Microbiome Dysbiosis: Resistome Dynamics, Metabolic Disruption, and Paths to Restoration.Antibiotics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Carbapenem resistance represents a critical global public health threat, with the rapid dissemination of carbapenemase genes largely mediated by plasmids. Although mobile genetic elements (MGEs), including transposons (Tn), insertion sequences (IS), and integrons (In), are known to drive this process, the mechanistic interplay between different MGE classes and the carbapenem resistome remains insufficiently characterized at a global scale. Methods: We performed a large-scale, systematic analysis of 6,017 plasmids carrying carbapenemase genes extracted from 72,556 complete plasmid sequences. Antimicrobial resistance genes were identified using AMRFinderPlus, and MGEs were detected through an integrative workflow combining TnCentral, INTEGRALL, ISFinder, ABRicate, and ISEScan. Functional associations between carbapenemase genes and MGEs were defined using a conservative genomic proximity threshold (≤5 kb). Statistical association analyses, network topology metrics, and a Mobilization-Resistance Score were applied to characterize mobilization strength and replicon-level dissemination potential. Results: Our analysis revealed a dual mechanistic architecture governing carbapenem resistance dissemination. Integrons and transposons acted as high-fidelity specialists, showing the strongest associations with carbapenemase genes (median ORs: 107.2 and 92.7, respectively). In contrast, insertion sequences exhibited lower individual association strength (median OR: 17.3) but structured the global mobilome network. IS6_292 emerged as the apex generalist, displaying the highest betweenness centrality (3,815.87) and forming significant associations with 13 distinct carbapenemase genes. At the replicon level, dissemination potential quantified by the Mobilization-Resistance Score identified IncFIB(pQil) and IncR as the most potent supervector platforms, despite the higher frequency of IncX3 and IncL plasmids. These replicons combine high MGE diversity with multiple carbapenemase genes, forming high-risk vectors for resistance acquisition and spread. Discussion: These findings demonstrate that carbapenemase dissemination is driven by complementary mobilization strategies: structurally specialized, high-strength transmission mediated by integrons and transposons, and structurally central, generalist dissemination mediated by insertion sequences. This duality reshapes the understanding of carbapenem resistome evolution and highlights structurally critical MGEs and high-scoring plasmid replicons as strategic surveillance targets. Focusing genomic monitoring on these elements may support the development of precision-based containment strategies to mitigate the global spread of carbapenem resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.